LD-2 disclosure · 1st Quarter - Report
ALNYLAM PHARMACEUTICALS, INC.
Client
- Name
- ALNYLAM PHARMACEUTICALS, INC.
- Description
- Biopharmaceutical company
- Location
- Massachusetts · United States of America
Registrant
- Description
- ​Government Affairs Consulting Firm.
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueMedicare/Medicaid
Medicare and Medicaid Issues. H.R.1672: Maintaining Investments in New Innovation Act. H.R.946: ORPHAN Cures Act.
LobbyistsDANIEL M TODD · PAUL EDATTEL · TED LEHMAN · KATHERINE FLEMING COTTON · ERIC BERGREN · mr NICOLAS MAGALLANES
Covered position (DANIEL M TODD): Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ctr. - Medicare & Medicaid
Covered position (PAUL EDATTEL): Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg
Covered position (TED LEHMAN): Chief of Staff, Senator Tillis; Senate Judiciary Committee-Counsel, then Chief Counsel for Nominations and Senior Counsel; Senate Judiciary Committee-Staff Assistant and Legislative Assistant
Covered position (KATHERINE FLEMING COTTON): Staff Assistant, Legislative Correspondent, Legislative Assistant - U.S. Representative Brett Guthrie
Covered position (ERIC BERGREN): Chief of Staff, Rep. Brett Guthrie; Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director, Chief of Staff - Rep. Ron Lewis; Intern, Rep. Bill Baker
Covered position (mr NICOLAS MAGALLANES): Senior Advisor - House Republican Conference; Policy Advisor/Professional Staff Member - U.S. Representative Lee Terry/Energy and Commerce Committee; Legislative Correspondent/Legislative Aide - U.S. Senator Lamar Alexander
TargetedSENATE · HOUSE OF REPRESENTATIVES
